Catalyst
Slingshot members are tracking this event:
Phase II data from SUMMIT basket trial of neratinib in patients with HER2 mutations expected Q2 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PBYI | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 02, 2017
Occurred Source:
http://www.pumabiotechnology.com/pr20170402_02.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Summit, Phase 2